[MYGN] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
06-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -169.74%
YoY- 48.10%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 177,800 156,400 179,300 164,900 160,800 167,300 189,400 -4.11%
PBT -52,100 -44,200 -17,900 -26,400 -43,500 39,800 -3,800 470.11%
Tax -9,800 -9,100 -3,800 -5,900 -35,900 15,200 900 -
NP -42,300 -35,100 -14,100 -20,500 -7,600 24,600 -4,700 330.94%
Tax Rate - - - - - -38.19% - -
Total Cost 220,100 191,500 193,400 185,400 168,400 142,700 194,100 8.71%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -23.79 -22.44 -7.86 -12.43 -4.73 14.70 -2.48 349.61%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.52 -0.43 -0.18 -0.26 -0.10 0.31 -0.06 320.26%
EPS Diluted -0.52 -0.43 -0.18 -0.26 -0.10 0.30 -0.06 320.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.